Innate Pharma S.A. reported its total number of shares outstanding and voting rights as of April 9, 2026, with 93,860,680 shares outstanding and 94,465,868 exercisable voting rights.
Key takeaways
The company's total number of shares outstanding as of April 9, 2026, is 93,860,680 shares, providing a baseline for ownership calculations.
Total exercisable voting rights stand at 94,465,868, reflecting the actual voting power available to shareholders after excluding treasury shares.
The share structure includes 93,847,763 ordinary shares and two classes of preferred shares (5,336 Preferred Shares 2016 and 7,581 Preferred Shares 2017).
Theoretical voting rights total 94,484,443, which includes shares with suspended voting rights and is used for calculating shareholding threshold crossings.